Clinical Trial Update: Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing dual versus triple lipid-lowering therapy in adults with type 2 diabetes and elevated LDL cholesterol; recruitment has not yet started…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Bahria University | Conditions: Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol | Phase 4 | Status: NOT_YET_RECRUITING